Patent · US Active

Imaging agents

US7811551B2 · kind B2 · utility

2Cited by

1References

2Claims

0Family size

Assignee

GE HEALTHCARE AS · NO

Inventors

Alan Cuthbertson · San Jose, US
Magne Solbakken · Oslo, NO

Key dates

Filing date	Jun 18, 2008
Grant date	Oct 12, 2010
Priority date	—
Expiry date	Jun 18, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds of formula (I): and their use as targeting vectors that bind to receptors associated with angiogenesis. Such compounds may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's sarcoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.